Research information · No products for sale
BPC-157: Human Evidence, Research and Safety
Why animal research on BPC-157 does not establish safety or benefit in people.
Published 20 October 2026 · Last reviewed 20 October 2026 · Editorial content by the Peptide Atelier UK team, not clinically reviewed
Editorial standards and corrections
BPC-157 is not an authorised medicine in the UK. It is not a cosmetic ingredient we use, and Peptide Atelier UK does not sell or supply it. This page is not medical advice; speak to a GP, pharmacist or other qualified healthcare professional.
Research status
BPC-157 ('body protection compound') is a synthetic 15-amino-acid peptide based on a sequence found in a protein in human gastric juice. It has not been authorised as a medicine by the MHRA or any major regulator.
Animal versus human evidence
Most published research involves rodents, often from a small number of research groups. Results in animals frequently fail to translate to humans. Robust, controlled clinical trials in people are lacking, so claims about healing, injury recovery or muscle growth are not established.
Limitations and unknowns
- Long-term safety in humans is unknown.
- Appropriate dosing, if any, has not been established.
- Interactions with other medicines and conditions are unknown.
- Theoretical concerns have been raised about effects on blood vessel growth.
Risks of unregulated products
BPC-157 is widely sold online as a 'research chemical'. Such products are not manufactured to pharmaceutical standards and may be mislabelled or contaminated. BPC-157 is also on the WADA Prohibited List for athletes.